Why It Matters
Baylor College of Medicine retained Brownstein Hyatt Farber Schreck LLP for its second quarter 2026 lobbying disclosure, signaling renewed engagement with the firm as Congress debates caps on indirect costs that fund campus infrastructure and research.
By the Numbers
Baylor spent $110,000 in total on lobbying in the second quarter of 2026. The firm fielded a 13-person team with considerable Hill pedigree, including Mark Warren, Stephen Holland, Harold Hancock, Russ Sullivan, Lexi Anicama, and Sapna Rampersaud.
Brownstein Hyatt Farber Schreck LLP acquired $21,630,000 in lobbying revenue from the first quarter of 2026 across 399 active clients and 1,294 active lobbying disclosures.
Broader Context
Congressional lobbying records show federal action may have triggered Baylor's engagement. The National Institute of Health (NIH) issued guidance in February 2025 capping indirect cost rates at 15 percent. Courts subsequently blocked the cap, but appropriations language in the Fiscal Year 2026 budget prohibits federal agencies from unilaterally capping negotiated rates without congressional approval.
Rep. Beth Van Duyne (R-TX-24) met with leaders from Baylor and other Texas universities in 2024 to discuss H.R. 7831, the Preventing Financial Exploitation in Higher Education Act, which targets institutions with high student loan default rates. That bill creates a distinct pressure point for universities managing federal compliance.
The Bottom Line
Baylor's congressional lobbying disclosure reflects the institution's multi-front engagement on research funding, student lending rules, and public health priorities. The team's tax and committee expertise positions the medical school to navigate ongoing disputes over how federal grant dollars flow to universities.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article